Investors are advised to stay calm amid volatility, focus on defensive stocks like HUL and NTPC, and watch for explosive ...

The MM-II trial was carried out in partnership with Israel-based Moebius Medical and included 397 patients in the US, Europe, ...

Discover the Sun Pharma Stock Liveblog, your ultimate resource for real-time updates and insightful analysis on a prominent ...

Sun Pharmaceutical Industries Ltd. closed 8.84% short of its 52-week high of 1,960.20 rupees, which the company reached on ...

MARKS & Spencer is working with spooks to find out whether foreign criminals were behind a cyber attack that has caused ...

Tariff worries continue hanging over companies as they report their latest financial results and try to provide guidance on ...

Reality TV is fun, but this felt like, ‘Oh, my gosh. This is it,'' the 'Hills' alum says of entering the world of daytime ...

Sun Pharmaceutical Industries Ltd. closed 7.94% short of its 52-week high of 1,960.20 rupees, which the company achieved on ...

Mumbai: Sun Pharma and Israel-based Moebius Medical Limited have announced the publication of two articles in Osteoarthritis ...

Private equity activity in healthcare remained resilient with 42 deals worth $562 million, just shy of last quarter’s $603 ...

If 340B is eliminated or weakened, large pharmaceutical companies will benefit at the expense of health care access across ...

Benchmark NSE Nifty50 index ended up 161.71 points at 24328.95, while the BSE Sensex stood up 520.9 points at 80116.49. Among ...